Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.

Expert opinion on pharmacotherapy 20120601

Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.

Andrologia 20120501

Comparison and efficacy of low-dose and standard-dose tamsulosin and alfuzosin in medical expulsive therapy for lower ureteral calculi: prospective, randomized, comparative study.

Korean journal of urology 20120501

The effects of systemic α₁-adrenoreceptor antagonists on pupil diameter.

The British journal of ophthalmology 20120401

Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.

Journal of pharmacy practice 20120401

The effect of alpha antagonists on pupil dynamics: implications for the diagnosis of intraoperative floppy iris syndrome.

American journal of ophthalmology 20120401

Combination pharmacological therapies for the management of benign prostatic hyperplasia.

Drugs & aging 20120401

Evaluation of a column classification method using the separation of alfuzosin from its related substances.

Journal of chromatography. A 20120316

2,4-Dichloro-7-fluoro-quinazoline.

Acta crystallographica. Section E, Structure reports online 20120301

Benign prostatic hyperplasia: from bench to clinic.

Korean journal of urology 20120301

Correlation between lower urinary tract symptoms and premature ejaculation in Korean men older than 40 years old [corrected].

Korean journal of urology 20120301

Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.

Biomedical chromatography : BMC 20120201

Chronic prostatitis: approaches for best management.

Korean journal of urology 20120201

In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.

Pharmaceutical development and technology 20120101

α-Blockers for benign prostatic hyperplasia: the new era.

Current opinion in urology 20120101

Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.

BJU international 20120101

Chronic pelvic pain syndrome and semen quality of Korean men in their fourth decade.

Journal of andrology 20120101

Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.

Biological & pharmaceutical bulletin 20120101

Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery.

International journal of molecular sciences 20120101

Neurogenic bladder.

Advances in urology 20120101

Lipases as catalysts in synthesis of fine chemicals.

Methods in molecular biology (Clifton, N.J.) 20120101

Floppy iris syndrome with oral imipramine: a case series.

Indian journal of ophthalmology 20120101

Medical management of renal stone.

Indian journal of endocrinology and metabolism 20120101

Pure small cell carcinoma of the prostate: A rare tumor.

Indian journal of urology : IJU : journal of the Urological Society of India 20120101

Prostatic relaxation induced by loperamide is reduced in spontaneously hypertensive rats.

TheScientificWorldJournal 20120101

[Management of intraoperative floppy iris syndrome].

Oftalmologia (Bucharest, Romania : 1990) 20120101

Various treatment options for benign prostatic hyperplasia: A current update.

Journal of mid-life health 20120101

Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.

BJU international 20111201

Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.

International urology and nephrology 20111201

Effects of pulsed electromagnetic fields on benign prostate hyperplasia.

International urology and nephrology 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Analysis of prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors from the urology department and other departments.

International neurourology journal 20111201

Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue.

Urology 20111001

National-wide data on the treatment of BPH in Korea.

Prostate cancer and prostatic diseases 20110901

Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence.

European urology 20110901

Treatment with a uroselective α1-blocker improves voiding and sexual function: a study in Thai men with lower urinary tract symptoms.

The journal of sexual medicine 20110901

Changes in sexual function in benign prostatic hyperplasia patients taking dutasteride: 1-year follow-up results.

Korean journal of urology 20110901

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

International neurourology journal 20110901

Efficacy of anticholinergics for chronic prostatitis/chronic pelvic pain syndrome in young and middle-aged patients: a single-blinded, prospective, multi-center study.

International neurourology journal 20110901

Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction.

International urogynecology journal 20110701

Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.

Analytical and bioanalytical chemistry 20110701

Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial.

International journal of urology : official journal of the Japanese Urological Association 20110701

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia.

Korean journal of urology 20110701

Postural hypotension.

BMJ (Clinical research ed.) 20110616

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.

Prostate cancer and prostatic diseases 20110601

Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.

Urology 20110601

Tamsulosin Monotherapy versus Combination Therapy with Antibiotics or Anti-Inflammatory Agents in the Treatment of Chronic Pelvic Pain Syndrome.

International neurourology journal 20110601

The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.

Urology 20110501

Risk factors for intraoperative floppy iris syndrome: a meta-analysis.

Ophthalmology 20110401

Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study.

World journal of urology 20110401

Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling.

Drug development and industrial pharmacy 20110401

Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

Korean journal of urology 20110401

Most bothersome symptom and symptom specific goal achievement in patients with benign prostatic obstruction: a prospective open label study.

The Journal of urology 20110301

Second prize: In-vivo physiological impact of alpha blockade on the porcine ureter with distal ureteral obstruction.

Journal of endourology 20110301

Depressogenic effects of medications: a review.

Dialogues in clinical neuroscience 20110301

[Recurrent hepatocellular lesion due to alfuzosin].

Gastroenterologia y hepatologia 20110201

Benign prostatic hyperplasia: An overview of existing treatment.

Indian journal of pharmacology 20110201

Identification, pharmacologic considerations, and management of prostatitis.

The American journal of geriatric pharmacotherapy 20110201

Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.

Korean journal of urology 20110101

The role of intraprostatic inflammation in the acute urinary retention.

International journal of preventive medicine 20110101

[Efficacy of prostatic adenoma treatment with alfusozine depending on sexuality].

Urologiia (Moscow, Russia : 1999) 20110101

Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones.

International braz j urol : official journal of the Brazilian Society of Urology 20110101

Management of ureteral calculi and medical expulsive therapy in emergency departments.

Journal of emergencies, trauma, and shock 20110101

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Clinical interventions in aging 20110101

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia.

Therapeutics and clinical risk management 20110101

Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.

Prostate cancer and prostatic diseases 20101201

Ejaculatory failure after unilateral neurolytic celiac plexus block.

The Korean journal of pain 20101201

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events.

International neurourology journal 20101201

Analysis of initial baseline clinical parameters and treatment strategy associated with medication failure in the treatment of benign prostatic hyperplasia in Korea.

International neurourology journal 20101201

Alfuzosin induced thrombocytopenia after treatment for benign prostatic hyperplasia.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20101201

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

Korean journal of urology 20101001

[Our experience with the use of alpha-lithic therapy in the treatment of voiding dysfunction].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica 20101001

Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.

The journal of sexual medicine 20100901

Stent Position Is More Important than α-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study.

Korean journal of urology 20100901

Acute hepatitis associated with the use of levofloxacin.

Clinical therapeutics 20100901

Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.

Korean journal of urology 20100701

Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.

Dermatology online journal 20100615

Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Urology 20100601

[Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases].

Revue de stomatologie et de chirurgie maxillo-faciale 20100601

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

The Journal of urology 20100501

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro.

European urology 20100401

Chuanxiongzine relaxes isolated corpus cavernosum strips and raises intracavernous pressure in rabbits.

International journal of impotence research 20100301

Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study.

Korean journal of urology 20100301

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.

World journal of urology 20100201

An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia.

International journal of clinical practice 20100201

Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.

World journal of urology 20100201

Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

International journal of clinical practice 20100101

The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?

Journal of pharmacological sciences 20100101

Tamsulosin-induced severe hypotension during general anesthesia: a case report.

Journal of medical case reports 20100101

Silodosin in the treatment of benign prostatic hyperplasia.

Drug design, development and therapy 20100101

Encrusted and incarcerated urinary bladder catheter: what are the options?

The Libyan journal of medicine 20100101

Direct injection liquid chromatography/positive ion electrospray ionization mass spectrometric quantification of methotrexate, folinic acid, folic acid and ondansetron in human serum.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091115

The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.

Journal of endourology 20091101

Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.

The Cochrane database of systematic reviews 20091007

Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

BJU international 20091001

[Use of alfuzosin for expulsion of stones in the distal third of ureter].

Actas urologicas espanolas 20091001

Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.

International journal of impotence research 20090901

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

British journal of cancer 20090901

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

BJU international 20090801

Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.

European urology 20090801

Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20090801

Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Current cardiology reviews 20090801

Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC.

Pakistan journal of pharmaceutical sciences 20090701

Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.

The Journal of pharmacy and pharmacology 20090701

Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090701

Words of wisdom. Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. Nickel JC, Krieger JN, McNaughton-Collins M, et al; Chronic Prostatitis Collaborative Research Network. N Engl J Med 2008;359:2663-73.

European urology 20090701

Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier.

Drug metabolism and disposition: the biological fate of chemicals 20090601

Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones.

Urology 20090401

Prostatitis: no benefit of alpha-blockers for chronic prostatitis.

Nature reviews. Urology 20090401

Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.

Biotechnology journal 20090301

Effect of alfuzosin on female primary bladder neck obstruction.

International urogynecology journal and pelvic floor dysfunction 20090201

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.

The journal of sexual medicine 20090201

Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study.

The Journal of urology 20090101

Watchful waiting in benign prostatic hyperplasia.

Current opinion in urology 20090101

Sexuality and the management of BPH with alfuzosin (SAMBA) trial.

International journal of impotence research 20090101

Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study.

Journal of andrology 20090101

Validation of a voltage-sensitive dye (di-4-ANEPPS)-based method for assessing drug-induced delayed repolarisation in beagle dog left ventricular midmyocardial myocytes.

Journal of pharmacological and toxicological methods 20090101

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.

Clinical interventions in aging 20090101

Can open-label studies demonstrate efficacy in improving sexual function?

International journal of impotence research 20090101

Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.

Urologia internationalis 20090101

Finasteride in the treatment of patients with benign prostatic hyperplasia: a review.

Therapeutics and clinical risk management 20090101

Drugs associated with more suicidal ideations are also associated with more suicide attempts.

PloS one 20090101

Therapeutic options in the treatment of benign prostatic hyperplasia.

Patient preference and adherence 20090101

Ureteral stent discomfort: Etiology and management.

Indian journal of urology : IJU : journal of the Urological Society of India 20090101

A prospective randomized study comparing alfuzosin and tamsulosin in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia.

Indian journal of urology : IJU : journal of the Urological Society of India 20090101

Alfuzosin hydrochloride transdermal films: evaluation of physicochemical, in vitro human cadaver skin permeation and thermodynamic parameters.

International braz j urol : official journal of the Brazilian Society of Urology 20090101

Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

Reviews in urology 20090101

[Administration of two uroselective alpha-adrenoblockers in pharmacological treatment of acute urinary retention in patients with prostatic adenoma].

Urologiia (Moscow, Russia : 1999) 20090101

Finasteride-its impact on sexual function and prostate cancer.

Journal of cutaneous and aesthetic surgery 20090101

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit.

Indian journal of pharmaceutical sciences 20090101

Recent advances in management of ureteral calculi.

F1000 medicine reports 20090101

Determination of Glucose Concentration in Aqueous Solution Using ATR-WT-IR Technique.

Sensors (Basel, Switzerland) 20090101

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.

The New England journal of medicine 20081218

Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective alpha1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081215

Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction.

BJU international 20081201

The role of combination medical therapy in benign prostatic hyperplasia.

International journal of impotence research 20081201

Alpha antagonists and intraoperative floppy iris syndrome: A spectrum.

Clinical ophthalmology (Auckland, N.Z.) 20081201

A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.

International journal of clinical practice 20081001

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.

Clinical interventions in aging 20080901

Selective and automated sample pretreatment by molecularly imprinted polymer for the analysis of the basic drug alfuzosin from plasma.

Journal of chromatography. A 20080704

Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

International journal of clinical practice 20080701

Intraoperative floppy-iris syndrome associated with systemic alpha blockers.

Journal of cataract and refractive surgery 20080701

Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study.

The Journal of urology 20080601

Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.

Journal of Korean medical science 20080601

[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].

Harefuah 20080601

Combination of alfuzosin and tadalafil exerts in vitro an additive relaxant effect on human corpus cavernosum.

The journal of sexual medicine 20080401

Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.

International journal of clinical practice 20080401

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.

BJU international 20080401

Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonists.

The Annals of pharmacotherapy 20080401

Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.

Journal of cataract and refractive surgery 20080301

The concept of neurogenic inflammation.

BJU international 20080301

Role of alpha1-blockers in chronic prostatitis syndromes.

BJU international 20080301

Lower urinary tract symptoms and sexual dysfunction: a common approach.

BJU international 20080301

Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system.

International journal of pharmaceutics 20080204

In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.

European journal of pharmacology 20080202

Alfuzosin delays cardiac repolarization by a novel mechanism.

The Journal of pharmacology and experimental therapeutics 20080201

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.

Therapeutics and clinical risk management 20080201

Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.

International urology and nephrology 20080101

Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.

The Annals of pharmacotherapy 20080101

The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.

Annals of ophthalmology (Skokie, Ill.) 20080101

Fatal injection of ranitidine: a case report.

Journal of medical case reports 20080101

[Prevalence of ejaculatory dysfunction secondary to alpha-blocker therapy in patients with benign prostatic hyperplasia].

Actas urologicas espanolas 20080101

The prince and the pauper. A tale of anticancer targeted agents.

Molecular cancer 20080101

Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.

European journal of pharmacology 20071222

Medical management of benign prostatic hypertrophy.

The Canadian journal of urology 20071201

On-line solid-phase extraction with a monolithic weak cation-exchange column and simultaneous screening of alpha1-adrenergic receptor antagonists in human plasma.

Journal of separation science 20071101

Stability-indicating spectrophotometric and spectrofluorimetric methods for determination of alfuzosin hydrochloride in the presence of its degradation products.

Die Pharmazie 20071101

The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20071101

The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract.

European urology 20070901

Alfuzosin-induced acute liver injury.

The Korean journal of hepatology 20070901

Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.

The Journal of urology 20070801

Potentiometric sensors enabling fast screening of the benign prostatic hyperplasia drug alfuzosin in pharmaceuticals, urine and serum.

Combinatorial chemistry & high throughput screening 20070801

Current treatment options in the management of chronic prostatitis.

Therapeutics and clinical risk management 20070801

Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.

Journal of cataract and refractive surgery 20070701

Selective sample treatment using molecularly imprinted polymers.

Journal of chromatography. A 20070608

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

European urology 20070601

Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?

European urology 20070601

Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.

American journal of ophthalmology 20070601

Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20070601

Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20070601

The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.

Naunyn-Schmiedeberg's archives of pharmacology 20070501

Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.

International journal of urology : official journal of the Japanese Urological Association 20070501

Computational approach to the basicity of a series of alpha1-adrenoceptor ligands in aqueous solution.

Bioorganic & medicinal chemistry 20070415

Re: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers: W. J. Hellstrom and S. C. Sikka. J Urol 2006; 176: 1529-1533.

The Journal of urology 20070401

Neuropsychiatric consequences of cardiovascular medications.

Dialogues in clinical neuroscience 20070301

A review of combination therapy in patients with benign prostatic hyperplasia.

Clinical therapeutics 20070301

Update on the use of dutasteride in the management of benign prostatic hypertrophy.

Clinical interventions in aging 20070301

Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH).

Therapeutics and clinical risk management 20070301

Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.

Prostate cancer and prostatic diseases 20070101

Re: Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.

European urology 20070101

Identification of the patient with enlarged prostate: diagnosis and guidelines for management.

Osteopathic medicine and primary care 20070101

Intraoperative floppy iris syndrome associated with terazosin.

Indian journal of ophthalmology 20070101

Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.

International journal of impotence research 20070101

In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.

Pharmaceutical development and technology 20070101

Alpha blockers for the treatment of benign prostatic hyperplasia.

Reviews in urology 20070101

[The experience in postoperative administration of alpha-adrenoblockers].

Urologiia (Moscow, Russia : 1999) 20070101

Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.

Indian journal of urology : IJU : journal of the Urological Society of India 20070101

Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy.

Eye (London, England) 20061201

Alfuzosin (10 mg) does not affect blood pressure in young healthy men.

European urology 20061201

Molecularly imprinted polymers for the clean-up of a basic drug from environmental and biological samples.

Journal of chromatography. A 20061201

Comorbid LUTS and erectile dysfunction: optimizing their management.

Current medical research and opinion 20061201

Validated HPLC and HPTLC stability-indicating methods for determination of alfuzosin hydrochloride in bulk powder and pharmaceutical formulations.

Journal of separation science 20061201

Doxazosin in the treatment of benign prostatic hypertrophy: an update.

Clinical interventions in aging 20061201

Urethral syndrome: response to alpha-adrenergic blocking agents.

International urogynecology journal and pelvic floor dysfunction 20061101

Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.

BJU international 20061001

A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil.

International journal of clinical practice 20061001

Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.

The Journal of urology 20061001

Stuttering priapism after ingestion of alfuzosin.

Urology 20061001

Development and validation of a reversed-phase HPLC method for monitoring of synthetic reactions during the manufacture of a key intermediate of an anti-hypertensive drug.

Journal of separation science 20061001

Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.

The Journal of urology 20060901

[Drug therapy for benign prostatic syndrome (BPS)].

Aktuelle Urologie 20060901

Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist.

Archives of dermatology 20060701

The management of chronic prostatitis in men with HIV.

Current urology reports 20060701

The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.

BJU international 20060601

Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects.

Urology 20060601

The natural history of benign prostatic hyperplasia.

BJU international 20060401

Definition of at-risk patients: dynamic variables.

BJU international 20060401

Management of acute urinary retention.

BJU international 20060401

Impact of medical treatments for benign prostatic hyperplasia on sexual function.

BJU international 20060401

Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?

BJU international 20060401

Tablet induced dysphagia in oesophageal cancer.

Gut 20060401

The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.

BJU international 20060401

Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.

BJU international 20060401

Alfuzosin: an alpha1-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.

Expert opinion on pharmacotherapy 20060401

BPH: epidemiology and comorbidities.

The American journal of managed care 20060401

Treatment and pharmacologic management of BPH in the context of common comorbidities.

The American journal of managed care 20060401

Are all alpha-blockers created the same?

European urology 20060301

Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).

European urology 20060301

Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.

BJU international 20060301

Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.

BJU international 20060301

What's the point?

BJU international 20060301

Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia.

International journal of clinical practice 20060301

Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.

The Journal of urology 20060201

In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Naunyn-Schmiedeberg's archives of pharmacology 20060201

Three months' treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate.

Prostate cancer and prostatic diseases 20060101

Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.

Urologia internationalis 20060101

Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience.

The Journal of urology 20060101

Is there a role for alpha1-blockers in treating double-J stent-related symptoms?

Urology 20060101

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

Clinical therapeutics 20060101

Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha1-blockers.

Urologia internationalis 20060101

Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia.

Current pharmaceutical design 20060101

Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Drugs 20060101

'Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches'.

Journal of translational medicine 20060101

Treatment of benign prostatic hyperplasia in patients with cardiovascular disease.

Drugs & aging 20060101

The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.

Reviews in urology 20060101

[Diagnosis and treatment of urinary bladder dysfunctions in patients with nephrotuberculosis].

Urologiia (Moscow, Russia : 1999) 20060101

A prospective pilot study to validate the management protocol for patients presenting with acute urinary retention: a community-based, nonhospitalised protocol.

TheScientificWorldJournal 20060101

Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.

Journal of neurology, neurosurgery, and psychiatry 20051201

Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?

Ophthalmology 20051201

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

The Journal of urology 20051101

Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects.

Urology 20051001

Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20051001

The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis.

BJU international 20050901

Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.

Urology 20050801

Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.

The Canadian journal of urology 20050801

Re: Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

The Journal of urology 20050701

Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists.

BJU international 20050601

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

European urology 20050601

Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.

BJU international 20050501

Clinical assessment of drug-induced QT prolongation in association with heart rate changes.

Clinical pharmacology and therapeutics 20050401

The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.

BJU international 20050301

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

BJU international 20050301

Re: alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

The Journal of urology 20050301

The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo-controlled study.

European urology 20050301

Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.

The Journal of pharmacology and experimental therapeutics 20050201

A pharmacoepidemiological approach to investigating inappropriate physician prescribing in a managed care setting in Israel.

The American journal of managed care 20050201

Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.

Urology 20050101

[The role of alpha1-adrenoblocker alfuzosine in diagnostic-therapeutic algorithm of hyperactive urinary bladder management in women and selection of patients for treatment with M-cholinergic antagonists].

Urologiia (Moscow, Russia : 1999) 20050101

A comparative study on the safety and efficacy of tamsulosin and alfuzosin in the management of symptomatic benign prostatic hyperplasia: a randomized controlled clinical trial.

The Journal of international medical research 20050101

Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention*.

International urology and nephrology 20050101

A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.

Reviews in urology 20050101

Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation.

Clinical drug investigation 20050101

Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.

Clinical therapeutics 20041101

Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis.

Spinal cord 20041001

Alfuzosin-induced acute hepatitis in a patient with chronic liver disease.

The Annals of pharmacotherapy 20040901

Prostate size influences the outcome after presenting with acute urinary retention.

BJU international 20040901

New drugs 04. Part III.

Nursing 20040901

Ejaculatory dysfunction and alpha-adrenoceptor antagonists.

BJU international 20040801

[A suggested treatment algorithm in nocturnal enuresis with emphasis on partial responders].

Der Urologe. Ausg. A 20040701

Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

The Journal of urology 20040601

On call. My doctor gave me a prescription for Uroxatral to treat my enlarged prostate. I tried to look up this medicine in your Harvard Medical School Guide to Men's Health, but I couldn't find it. What can you tell me about Uroxatral?

Harvard men's health watch 20040601

[The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].

Zhonghua wai ke za zhi [Chinese journal of surgery] 20040522

Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.

BJU international 20040401

Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.

The Canadian journal of urology 20040401

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

The Journal of urology 20040301

A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats.

BJU international 20040301

The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.

European urology 20040301

Patients with bladder outlet obstruction who refuse treatment show no clinical and urodynamic change after long-term follow-up.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20040301

Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia.

The American journal of geriatric pharmacotherapy 20040301

Drug approval highlights for 2003.

The Nurse practitioner 20040201

A current review of medical therapy for benign prostatic hyperplasia.

The Journal of the American Osteopathic Association 20040201

Alfuzosin (uroxatral)--another alpha1-blocker for benign prostatic hyperplasia.

The Medical letter on drugs and therapeutics 20040105

Alfuzosin improves penile erection triggered by apomorphine in spontaneous hypertensive rats.

European urology 20040101

Real life practice in the management of benign prostatic hyperplasia.

Current opinion in urology 20040101

New drugs of 2003.

Journal of the American Pharmacists Association : JAPhA 20040101

[Can selective alpha-blockers help the spontaneous passage of the stones located in the uretero-bladder junction?].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20040101

A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.

Scandinavian journal of urology and nephrology 20040101

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

BJU international 20031201

Use of alpha-blockers and the risk of hip/femur fractures.

Journal of internal medicine 20031201

Alfuzosin for the management of benign prostate hyperplasia.

Expert opinion on pharmacotherapy 20031101

First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.

Urology 20031101

[Pharmacologic treatment of benign prostatic hyperplasia].

Orvosi hetilap 20030914

Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.

Urology 20030901

The Finnish version of The National Institutes Of Health Chronic Prostatitis Symptom Index correlates well with the visual pain scale: translation and results of a modified linguistic validation study.

BJU international 20030801

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

BJU international 20030801

Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030715

Prostatic tissual distribution of alfuzosin in patients with benign prostatic hyperplasia following repeated oral administration.

European urology 20030701

Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.

Circulation 20030617

Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum.

BJU international 20030601

Selective, sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of alfuzosin in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525

Current treatment options for benign prostatic hyperplasia and their impact on sexual function.

Urology 20030401

The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction.

The Journal of urology 20030201

Benign prostatic hyperplasia.

Hospital medicine (London, England : 1998) 20030201

Clinical and pressure-flow changes after long-term treatment with alfuzosin SR.

Urologia internationalis 20030101

Estimated costs of treatment of benign prostate hyperplasia in Brazil.

International braz j urol : official journal of the Brazilian Society of Urology 20030101

Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment.

Journal of clinical pharmacology 20021201

Alfuzosin in the treatment of high leak-point pressure in children with neurogenic bladder.

BJU international 20021101

Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.

European urology 20021001

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20021001

[Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results].

Der Urologe. Ausg. A 20020901

[alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness].

Der Urologe. Ausg. A 20020901

alpha-Adrenoceptor antagonists in the treatment of benign prostate hyperplasia.

Pharmacology 20020701

Alfuzosin, an alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia: once daily versus 3 times daily dosing in healthy subjects.

International journal of clinical pharmacology and therapeutics 20020701

[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].

Yao xue xue bao = Acta pharmaceutica Sinica 20020601

Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

The Journal of biological chemistry 20020419

Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.

The Journal of urology 20020401

Alfuzosin: a clinically uroselective alpha1-blocker.

World journal of urology 20020401

The use of alpha-adrenoceptor antagonists in lower urinary tract disease.

Expert opinion on pharmacotherapy 20020201

Tamsulosin: an update of its role in the management of lower urinary tract symptoms.

Drugs 20020101

[Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].

Urologiia (Moscow, Russia : 1999) 20020101

Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia.

Drugs 20020101

Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.

Drugs & aging 20020101

Long-term safety and efficacy of a once-daily formulation of alfuzosin 10 mg in patients with symptomatic benign prostatic hyperplasia: open-label extension study.

European urology 20020101

Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.

BMC urology 20020101

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial.

Urology 20011201

Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker.

Urology 20011201

Worldwide experience with alfuzosin and tamsulosin.

Urology 20011001

Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry 20010607

Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

Journal of clinical epidemiology 20010501

Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.

Urology 20010301

Does acute urinary retention respond to alpha-blockers alone?

European urology 20010301

Do alpha-blockers prevent the occurrence of acute urinary retention?

European urology 20010301

The efficacy and safety of a new once-a-day formulation of an alpha-blocker.

European urology 20010301

[Long-term therapy of benign prostatic hyperplasia. Our experience].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20010301

[Can PSA density predict the response to alpha-blockers in benign prostatic hyperplasia?].

Actas urologicas espanolas 20010201

alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

The Journal of urology 20010101

A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.

Naunyn-Schmiedeberg's archives of pharmacology 20010101

[Effectiveness of various alfuzosin schedules in patients with benign prostatic hyperplasia (BPH)].

Urologiia (Moscow, Russia : 1999) 20010101

Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: the role of general practice databases.

European urology 20010101

[Dalphaz-retard treatment of urination disorders in men and women].

Urologiia (Moscow, Russia : 1999) 20010101

Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

International urology and nephrology 20010101

Long-term aspects of medical treatment of BPH.

European urology 20010101

Initial choices and final outcomes in lower urinary tract symptoms.

European urology 20010101

Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.

International urology and nephrology 20010101

The efficacy of alfuzosin treatment in patients with prostatism.

International urology and nephrology 20010101

Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics.

Pharmaceutica acta Helvetiae 20000301

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

European urology 19990101

[Combined use of 5 alpha-reductase inhibitors and alpha-l adrenergic receptor blockers in patients with benign prostatic hyperplasia].

Urologiia i nefrologiia 19980101

Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.

British journal of urology 19971001

Prostatic alpha 1-adrenoceptors and uroselectivity.

The Prostate 19970215

Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.

Journal of medicinal chemistry 19950901

[Assessment of the effects of alfuzosin on miction with dynamic echography].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 19940901

Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

Urology 19940701

Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group.

Scandinavian journal of urology and nephrology. Supplementum 19940101

[Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].

Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma 19940101

Alpha-blocking treatment with alfuzosin in symptomatic benign prostatic hyperplasia: comparative study with prazosin. The PRAZALF Group.

British journal of urology 19931201

The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.

International journal of clinical pharmacology, therapy, and toxicology 19931101

Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.

British journal of pharmacology 19930801

Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Drugs 19930301

[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19920301

Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.

European urology 19920101

Peripubertal changes in the nature of the GnRH response to alpha-adrenoceptor stimulation in vitro and their modulation by testosterone.

Neuroendocrinology 19900701

A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats.

European journal of pharmacology 19861007